These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 10904500)

  • 1. Cost-effectiveness of pneumococcal vaccine.
    Meyerhoff AS; Jacobs RJ
    JAMA; 2000 Jul; 284(4):440-1. PubMed ID: 10904500
    [No Abstract]   [Full Text] [Related]  

  • 2. Cost-effectiveness of pneumococcal vaccine.
    Le C
    JAMA; 2000 Jul; 284(4):440; author reply 440-1. PubMed ID: 10904499
    [No Abstract]   [Full Text] [Related]  

  • 3. Projected cost-effectiveness of pneumococcal conjugate vaccination of healthy infants and young children.
    Lieu TA; Ray GT; Black SB; Butler JC; Klein JO; Breiman RF; Miller MA; Shinefield HR
    JAMA; 2000 Mar; 283(11):1460-8. PubMed ID: 10732936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    MMWR Recomm Rep; 1997 Apr; 46(RR-8):1-24. PubMed ID: 9132580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cost-effectiveness of pneumococcal vaccination of the elderly].
    Hak E; Grobbee DE; Verheij TJ
    Ned Tijdschr Geneeskd; 1998 Jan; 142(4):201-2; author reply 202-3. PubMed ID: 9557028
    [No Abstract]   [Full Text] [Related]  

  • 6. The pharmacoeconomics of pneumococcal conjugate vaccines in Latin America.
    Giglio N; Micone P; Gentile A
    Vaccine; 2011 Sep; 29 Suppl 3():C35-42. PubMed ID: 21896351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting cost-benefits before programs are started: looking at conjugate vaccine for invasive pneumococcal infections.
    Hueston WJ; Mainous AG; Brauer N
    J Community Health; 2000 Feb; 25(1):23-33. PubMed ID: 10706207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cost-effectiveness of pneumococcal vaccination in the elderly].
    van den Berg JW
    Ned Tijdschr Geneeskd; 1998 Jan; 142(4):202-3. PubMed ID: 9557029
    [No Abstract]   [Full Text] [Related]  

  • 9. From individual to herd protection with pneumococcal vaccines: the contribution of the Cuban pneumococcal conjugate vaccine implementation strategy.
    Linares-Pérez N; Toledo-Romaní ME; Santana-Mederos D; García-Fariñas A; García-Rivera D; Valdés-Balbín Y; Vérez-Bencomo V
    Int J Infect Dis; 2017 Jul; 60():98-102. PubMed ID: 28457742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of the pneumococcal vaccine in the United States Navy and Marine Corps.
    Vold Pepper P; Owens DK
    Clin Infect Dis; 2000 Jan; 30(1):157-64. PubMed ID: 10619745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of vaccination against pneumococcal bacteremia among elderly people.
    Sisk JE; Moskowitz AJ; Whang W; Lin JD; Fedson DS; McBean AM; Plouffe JF; Cetron MS; Butler JC
    JAMA; 1997 Oct 22-29; 278(16):1333-9. PubMed ID: 9343464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Convincing or confusing? Economic evaluations of childhood pneumococcal conjugate vaccination--a review (2002-2006).
    Beutels P; Thiry N; Van Damme P
    Vaccine; 2007 Feb; 25(8):1355-67. PubMed ID: 17208339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pneumococcal conjugate vaccines.
    Watson W
    Pediatr Infect Dis J; 2000 Apr; 19(4):331-2. PubMed ID: 10783025
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of pneumococcal polysaccharide vaccine in children.
    Mulholland K; Usen S; Adegbola R; Weber M
    Lancet; 1998 Aug; 352(9127):575-6. PubMed ID: 9716087
    [No Abstract]   [Full Text] [Related]  

  • 15. A pharmacoeconomic evaluation of seven-valent pneumococcal conjugate vaccine in Spain.
    Asensi F; De Jose M; Lorente M; Moraga F; Ciuryla V; Arikian S; Casciano R; Vento M
    Value Health; 2004; 7(1):36-51. PubMed ID: 14720129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [An antipneumococcal vaccination program for the elderly of Bologna].
    Roveri P; Faggioli A; Gianninoni AR; Agostini D
    Ann Ig; 1999; 11(4):319-27. PubMed ID: 10520525
    [No Abstract]   [Full Text] [Related]  

  • 17. Pneumococcal conjugate vaccine. What you need to know.
    S D Med; 2006 Dec; 59(12):528-9. PubMed ID: 17212186
    [No Abstract]   [Full Text] [Related]  

  • 18. [Anti-pneumococcal vaccination in elderly persons].
    Trivalle C
    Presse Med; 1998 Mar; 27(10):484-8. PubMed ID: 9767984
    [No Abstract]   [Full Text] [Related]  

  • 19. Cost effectiveness of adding 7-valent pneumococcal conjugate (PCV-7) vaccine to the Norwegian childhood vaccination program.
    Wisløff T; Abrahamsen TG; Bergsaker MA; Løvoll Ø; Møller P; Pedersen MK; Kristiansen IS
    Vaccine; 2006 Jul; 24(29-30):5690-9. PubMed ID: 16735083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of conjugate pneumococcal vaccination in Singapore: comparing estimates for 7-valent, 10-valent, and 13-valent vaccines.
    Tyo KR; Rosen MM; Zeng W; Yap M; Pwee KH; Ang LW; Shepard DS
    Vaccine; 2011 Sep; 29(38):6686-94. PubMed ID: 21745516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.